Related Experiment Video
Updated: Aug 19, 2026

A Novel Approach for the Administration of Medications and Fluids in Emergency Scenarios and Settings
Published on: November 9, 2016
Medication refusal and judicial activism: a reexamination of the effects of the Rivers decision
J R Ciccone1, J F Tokoli, T E Gift
1Department of Psychiatry, University of Rochester School of Medicine and Dentistry, New York 14642.
Objective:
In 1986 New York State courts in Rivers v. Katz mandated judicial review of cases in which involuntarily hospitalized psychiatric patients formally refuse medications; previously only a clinical-administrative review was required. In an earlier study the authors found that formal refusals of medications declined significantly in the year after the Rivers decision and that length of time between refusal and its resolution increased. To determine whether these effects were maintained over time, data for the second year after the Rivers decision were examined.
Methods:
Chi square analysis and analysis of variance were used to compare data from both a private and a state-operated hospital for the year before the Rivers decision with data from the first and second years after.
Results:
The significant declines in the number of patients formally refusing medications were maintained in the second year after Rivers at both hospitals, as were the significant increases in the length of time to resolution. In the second year, judges continued to uphold the treating psychiatrists' recommendations. The decline in the refusal rates was not found to be part of a broader trend that had been manifest before the Rivers decision.
Conclusions:
The sharp decline in refusals resulted in fewer patients having their medications reviewed by others not directly involved in their care. Increased time to resolution has diminished quality of care and has resulted in increased patient decompensation and staff injuries.
Related Concept Videos
Obedience
Ethical Issues
Ethical Concerns in Healthcare:
Standards of Care II
Drug Regulation
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Drug Control Governance: Regulatory Bodies and Their Impact

